...products, and will share with Cancer Research and Duke any revenues generated from therapeutic licenses. Oncormed Inc....

...District of Columbia (see BioCentury, Nov. 24). Myriad Genetics Inc. (MYGN), Salt Lake City, Utah OncorMed Inc....

...Wetherbee as VP of business development, formerly VP of business development and strategic planning at Oncormed Inc. WIR...

...The companies expanded a 1997 agreement originally signed between RPR and Oncormed Inc., which GLGC acquired in...

...will have 19.6 million shares outstanding after the acquisition. Gene Logic Inc. (GLGC), Gaithersburg, Md. Oncormed Inc....

...transcription. OSIP closed Friday at $6.375, up 17 percent on the week . . . OncorMed...

...relevance and profiles patients for pharmacogenomic or therapeutic purposes. Gene Logic Inc. (GLGC), Gaithersburg, Md. Oncormed Inc....

...Inc. (GLGC), Gaithersburg, Md. Business: Drug discovery Transition: Douglas Dolginow, formerly president and CEO of Oncormed Inc....

...relating to BRCA1 are exclusively licensed to Myriad Genetics Inc. (MYGN, Salt Lake City, Utah). Oncormed Inc....

...the entire normal BRCA1 protein in humans. Mutations in BRCA1 are associated with breast cancer. Oncormed Inc....